1-12 of 12
Hong Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In-Class Transition (iCT) of Proteasome Inhibitor-Based Therapy Prolongs Progression-Free Survival in High-Risk Myeloma Patients: A Real-World Chinese Cohort Study

Rong Fu, Hong Yu, Aijun Liu, Rui Hou, Zunmin Zhu, Junling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, ARong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Deqiang Zheng, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 7846.
https://doi.org/10.1182/blood-2024-209471
Published: 2024
Journal Articles

Ixazomib, Pomalidomide and Dexamethasone (IxaPD) Pan-Oral Regimen in the Treatment of Refractory and Relapsed Multiple Myeloma

Miao Chen, Hong Yu, Aijun Liu, Wei Wang, Xiaoqi Qin, Ziping Li, Yanping Ma, Wenming Chen, Rong Fu, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7038.
https://doi.org/10.1182/blood-2024-210284
Published: 2024
Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2041.
https://doi.org/10.1182/blood-2024-208043
Published: 2024
Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial

Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao
Journal: Blood
Blood (2022) 140 (Supplement 1): 3739–3740.
https://doi.org/10.1182/blood-2022-164677
Published: 2022
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimen for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Hong Yu, Lei Shi, Wei-wei Tian, Qinhua Liu, Dongmei Zou, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Wanling Sun, Liangming Ma, Li Bao, Rong Fu, Yin Wu, Chen Wenming, Junling Zhuang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12637–12639.
https://doi.org/10.1182/blood-2022-169057
Published: 2022
Journal Articles

Successful Ex Vivo Telomere Elongation with Exg-001 in a Patient with a Dyskeratosis Congenita

Kasiani C. Myers, Stella M Davies, Carolyn Lutzko, Robin Wahle, Geraldine Aubert, Tomokazu Amano, Misa Amano, Hong Yu, Minoru S.H. Ko
Journal: Blood
Blood (2022) 140 (Supplement 1): 1895–1896.
https://doi.org/10.1182/blood-2022-164978
Published: 2022
Journal Articles

Lenalidomide Versus Thalidomide or Bortezomib As Maintenance Regimens for Non-Transplant Patients with Multiple Myeloma: Multi-Center Real World Experience in China

Zhe Zhuang, Lei Shi, Ying Tian, Dongmei Zou, Ru Feng, Fei Dong, Yanping Ma, Hong Yu, Wei-wei Tian, Shuangjiao Liu, Liangming Ma, Rong Fu, Hongmei Jing, Hui Liu, Wanling Sun, Chen Wenming, Yin Wu, Li Bao, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4728.
https://doi.org/10.1182/blood-2021-149502
Published: 2021
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Wei-wei Tian, Hong Yu, Dongmei Zou, Qinhua Liu, Lei Shi, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Li Bao, Wanling Sun, Rong Fu, Liangming Ma, Chen Wenming, Yin Wu, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4766.
https://doi.org/10.1182/blood-2021-152542
Published: 2021
Journal Articles

Sequential Intravenous to Oral Proteasome Inhibitor Based Regimens for the Treatment of Newly Diagnosed Multiple Myeloma Patients: A Real-World Study

Aijun Liu, Rong Fu, PhD, Zunmin Zhu, Li Bao, MD, Huizheng Bao, Da Gao, MD, Yanping Ma, PhD, Chen Wenming, MD, Hong Yu
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-139064
Published: 2020
Journal Articles

Low-dose chidamide restores immune tolerance in ITP in mice and humans

Hong-yu Zhao, Ya-hui Ma, Da-qi Li, Tao Sun, Li-zhen Li, Ping Li, Xin-guang Liu, Hai Zhou, Yu Hou, Yang Liu, Pan-pan Han, Ya-jing Zhao, Fang-miao Jing, Jun Peng, Ming Hou
Journal: Blood
Blood (2019) 133 (7): 730–742.
https://doi.org/10.1182/blood-2018-05-847624
Published: 2019
Includes: Supplemental data
Journal Articles

CD28-mediated regulation of multiple myeloma cell proliferation and survival

Nizar J. Bahlis, Anne M. King, Despina Kolonias, Louise M. Carlson, Hong Yu Liu, Mohamad A. Hussein, Howard R. Terebelo, Gerald E. Byrne, Jr, Bruce L. Levine, Lawrence H. Boise, Kelvin P. Lee
Journal: Blood
Blood (2007) 109 (11): 5002–5010.
https://doi.org/10.1182/blood-2006-03-012542
Published: 2007
Journal Articles

Plasminogen activator inhibitor type 2: a regulator of monocyte proliferation and differentiation

Hong Yu, Fabienne Maurer, Robert L. Medcalf
Journal: Blood
Blood (2002) 99 (8): 2810–2818.
https://doi.org/10.1182/blood.V99.8.2810
Published: 2002